- $770.88m
- $883.00m
- $66.40m
- 43
- 20
- 53
- 32
2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K |
Standards: | USG | USG | USG |
Status: | Final | Final | Final |
Revenue | |||
Total Revenue | 1.2 | 44.7 | 66.4 |
Cost of Revenue | |||
Gross Profit | 0.464 | 38.5 | 59.9 |
Selling / General / Administrative Expenses | |||
Depreciation and Amortization | |||
Unusual Expense / Income | |||
Other Operating Expenses | |||
Total Operating Expenses | 1.33 | 11 | 44.4 |
Operating Profit | -0.134 | 33.7 | 22 |
Total Net Non Operating Interest Income / Expense | |||
Total Net Non Operating Interest Income / Expense | |||
Other Net Non Operating Costs | |||
Net Income Before Taxes | -0.134 | 33.3 | 10.5 |
Provision for Income Taxes | |||
Net Income After Taxes | -0.134 | 32.4 | 9.03 |
Minority Interest | |||
Net Income Before Extraordinary Items | |||
Net Income | 0.015 | 31.7 | 9.52 |
Adjustments to Net Income | |||
Income Available to Common Shareholders Excluding Extraordinary Items | |||
Income Available to Common Shareholders Including Extraordinary Items | |||
Diluted Net Income | 0.015 | 31.7 | 9.52 |
Diluted Weighted Average Shares | |||
Basic EPS Including Extraordinary Items | |||
Diluted EPS Including Extraordinary Items | |||
Diluted EPS Excluding Extraordinary Items | |||
Normalised Income Before Taxes | |||
Normalised Income After Taxes | |||
Normalised Income Available to Common Shareholders | |||
Diluted Normalised EPS | 0 | 0.5 | 0.196 |
Dividends per Share |